Compensation 990
OrganizationsEmployeesBoard MembersGrantsContractorsTop RankingsPricing

Stay updated on 990 organization compensation

© Civic Register LLC

Compensation 990 is an independent service that uses public IRS Form 990 filings as its source data. We clean and standardize this information, but the original filings may contain errors or omissions. Years on this site refer to the organization’s fiscal year end date on the filing.

About•Report a discrepancy•Your privacy choices
Organizations Diseases, Disorders & Medical Neuroendocrine Tumor Research Foundation

Neuroendocrine Tumor Research Foundation

Fiscal year ending 2022. Filed on May 8, 2023.

31 St James Avenue 365
Boston, Massachusetts 02116

Neuroendocrine Tumor Research Foundation (EIN: 20-1945347) has filed an IRS Form 990 since fiscal year 2019. In its fiscal year 2022 IRS Form 990 filing, Neuroendocrine Tumor Research Foundation, a 501(c)(3) charitable organization, reported compensation for 4 out of 9 total employees. Among the employees shown here, the average compensation is $153,590. The highest compensated employee at Neuroendocrine Tumor Research Foundation is Elyse Gellerman with fiscal year 2022 compensation of $202,617.

Revenue, expenses, and employee compensation

Revenue

$3,075,371

Expenses

$3,490,037

Employee compensation

$840,447
Revenue, expenses, and employee compensation over time

Reported Compensated Employees

Elyse Gellerman
Chief Executive Officer
$202,617
$202,617 No related compNo other comp
John Kanki
Research Director
$184,574
$184,574 No related compNo other comp
Susan H Payson
Chief Development Officer
$118,711
$118,711 No related compNo other comp
Christine Coffey
Communications Director
$108,456
$108,456 No related compNo other comp

Benchmark Employee Compensation

Non-Employee Board Members

Anthony Detre
Director
Brendan Foley
Clerk
Dr Joseph Li
Director
Jonathan Soroff
Director
Josh Mailman
Treasurer
Julie Shaffer Mebane
Vice President
Laurie Rains
Director
Mark Lewis
Director
Stephen Blackwood
Director
Stephen Kaufer
Director
Suzanne Ludlow
Director
Todd Gilman
President

Mission Statement

TO FUND RESEARCH TO DISCOVER CURES AND MORE EFFECTIVE TREATMENTS FOR NEUROENDOCRINE CANCERS. THE NETRF IS COMMITTED TO IMPROVING THE LIVES OF THOSE AFFECTED BY NEUROENDOCRINE CANCER BY PROVIDING INFORMATION & EDUCATIONAL RESOURCES.

Revisions to this organization profile

April 30, 2025:
2024 Neuroendocrine Tumor Research Foundation 990 filed
April 23, 2024:
2023 Neuroendocrine Tumor Research Foundation 990 filed
May 8, 2023:
2022 Neuroendocrine Tumor Research Foundation 990 filed

Get an email when new compensation information is released for Neuroendocrine Tumor Research Foundation

Be the first to know when new IRS Form 990 data is published for this organization.

Related Jobs

View more jobs
Powered by Talroo
Report a discrepancy →